Table 3.
Adjusted Odds of Adverse Outcomes Compared to Single Agent, BP<140/90 mm Hg
Multiple Agent <140/90 |
Single Agent ≥140/90 | Multiple Agent ≥140/90 |
|
---|---|---|---|
Superimposed Preeclampsia* |
1.35 (0.75-2.46) | 2.04 (1.15-3.63) | 2.27 (1.19-4.28) |
Superimposed Severe PE* |
1.34 (0.64-2.81) | 1.33 (0.63-2.83) | 2.86 (1.41-5.77) |
Cesarean Delivery† | 0.89 (0.51-1.53) | 1.04 (0.60-1.81) | 1.25 (0.64-2.45) |
Admissions to r/o PE‡ | 3.18 (1.56-6.51) | 2.44 (1.12-5.31) | 3.21 (1.36-7.58) |
SGA§ | 1.36 (0.65-2.86) | 1.40 (0.68-2.88) | 1.82 (0.81-4.07) |
PTB <35 weeks∥ | 1.35 (0.73-2.46) | 1.97 (1.09-3.56) | 3.05 (1.59-5.83) |
Composite Neonatal ** | 1.63 (0.82-3.25) | 1.72 (0.86-3.45) | 3.84 (1.96-7.50) |
Adjusted for history of preeclampsia, nulliparity
Adjusted for prior vaginal delivery, diabetes, tobacco use
Adjusted for diabetes
Adjusted for race, body mass index, diabetes, and tobacco use
Adjusted for prior preterm delivery, nulliparity
Adjusted for nulliparity